ArticleJACC. Case reports2026
Unexplained Supraventricular Tachycardia and Myocardial Injury After Bitter Orange Supplement Use in a Young Woman.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBitter orange (Citrus aurantium) is a common ingredient in weight-loss supplements and contains p-synephrine, a proto-alkaloid with sympathomimetic properties. Various cardiovascular adverse events have been reported after its use. CASE SUMMARY: A 38-year-old woman without cardiovascular risk factors presented with palpitations, atypical chest pain, and vomiting after 1 week of weight-loss-supplement use. Electrocardiography showed a supraventricular tachycardia, successfully terminated with 6 mg of intravenous adenosine. High-sensitivity troponin I rose from 17.9 to 1,395.7 ng/L. Transthoracic echocardiography was unremarkable, computed tomography pulmonary angiography excluded pulmonary embolism, and coronary angiography showed no obstructive coronary artery disease. Cardiac magnetic resonance demonstrated nonspecific late gadolinium enhancement. DISCUSSION: This case highlights a possible association between bitter orange supplement use and supraventricular tachycardia with myocardial injury in the absence of obstructive coronary disease. The likely mechanism involves p-synephrine-mediated sympathetic stimulation, with possible demand ischemia and/or vasospasm.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.